Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain

Nicolas Ardes-Guisot, Dominic S. Alonzi, Gabriele Reinkensmeier, Terry D. Butters, Caroline Norez, Frédéric Becq, Yousuke Shimada, Shinpei Nakagawa, Atsushi Kato, Yves Blériot*, Matthieu Sollogoub, Boris Vauzeilles

*この論文の責任著者

研究成果: ジャーナルへの寄稿学術論文査読

44 被引用数 (Scopus)

抄録

A series of neoglycoconjugates derived from deoxynojirimycin has been prepared by click connection with functionalised adamantanes. They have been assayed as glycosidase inhibitors, as inhibitors of the glycoenzymes relevant to the treatment of Gaucher disease, as well as correctors of the defective ion-transport protein involved in cystic fibrosis. We have demonstrated that it is possible to selectively either strongly inhibit ER-α-glucosidases and ceramide glucosyltransferase or restore the activity of CFTR in CF-KM4 cells by varying the length of the alkyl chain linking DNJ and adamantane.

本文言語英語
ページ(範囲)5373-5388
ページ数16
ジャーナルOrganic and Biomolecular Chemistry
9
15
DOI
出版ステータス出版済み - 2011/08/07

ASJC Scopus 主題領域

  • 生化学
  • 物理化学および理論化学
  • 有機化学

フィンガープリント

「Selection of the biological activity of DNJ neoglycoconjugates through click length variation of the side chain」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル